Cambridge Cancer Genomics
Cambridge Cancer Genomics, based in Cambridge, England, is a healthcare diagnostics company with a team of 25, focusing on the UK and European markets.
Company Overview
Cambridge Cancer Genomics (CCG) operates in the healthcare industry, specifically within the diagnostics sub-sector. The company is based in Cambridge, England, United Kingdom, and serves regions across the United Kingdom and Europe. The company is a small team with a size of 25 members and was part of the Y-Combinator Summer 2017 batch (S17).
Locations and Regions of Operation
Cambridge Cancer Genomics is headquartered in Cambridge, England, United Kingdom. The company's operations extend beyond the local region to encompass the entire United Kingdom and parts of Europe. This positioning allows the company to engage with a broader market within the healthcare diagnostics industry.
Team Size and Structure
Cambridge Cancer Genomics comprises a small, dedicated team of 25 members. The size enables agility and close-knit collaboration within the company, essential for maintaining advancements in healthcare diagnostics. Being a compact team likely offers a level of flexibility in responding to the rapidly changing dynamics of the healthcare industry.
Y-Combinator Involvement
Cambridge Cancer Genomics was selected to be part of the Y-Combinator Summer 2017 (S17) batch. This inclusion in the renowned startup accelerator program underscores the company's commitment to innovation in the field of healthcare diagnostics and provides a solid foundation for growth and development.
Domain Name Sale
The domain name CCG.ai associated with Cambridge Cancer Genomics is available for sale. Priced at $49,995 USD, the purchase includes a complimentary logo design and a payment plan option. The domain price also features a 100% purchase protection guarantee and promises a swift transfer process, typically initiated within 24 hours of purchase.